Figures computed from official regulatory filings — .
Ownershipinsiders 19.75% · institutions 0.4%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for CROSSJECT only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. It offers Midazolam for epileptic seizure; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
15 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Eric Nemeth | Award | $22.1K | AMF |
| Marie-Anne Nemeth | Award | $1.9K | AMF |
| Eric Nemeth | Award | $5.3K | AMF |
| Marie-Anne Nemeth | Award | $1.7K | AMF |
| Eric Nemeth | Award | $25.6K | AMF |
| Patrick ALEXANDREtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 46 | AMF |
| GEMMES VENTURE | AwardD (derivative) | $502.3K | AMF |
| GEMMES VENTURE | Award | $2.1M | AMF |
| ISABELLE LIEBSCHUTZ | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 75ClusterFirst in 12mo | AMF |
| Olivier GIRE | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 61ClusterFirst in 12mo | AMF |
| Patrick ALEXANDREtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 38 | AMF |
| Eric Nemeth | Award | $21.7K | AMF |
| Eric Nemeth | Award | $52.1K | Unusual size | AMF |
| Marie-Anne Nemeth | Award | $20.8K | AMF |
| philippe monnot | Award | $20.3K | AMF |
| GEMMES VENTURE | Award | $2.1M | AMF |
| Patrick ALEXANDREtrack record | Buy | $11.1K | conv 55First in 12mo | AMF |
| Marie-Anne Nemeth | Award | $758.9 | AMF |
| Eric Nemeth | Award | $7K | AMF |
| GEMMES VENTURE | Other | $80.6K | AMF |
| Patrick ALEXANDREtrack record | Buy | $177.6K | conv 65Cluster | AMF |
| Eric Nemeth | Award | $8.1K | AMF |
| Patrick ALEXANDREtrack record | Buy | $5.2K | conv 52Cluster | AMF |
| Patrick ALEXANDREtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 61ClusterFirst in 12mo | AMF |
| Marie-Anne Nemeth | Award | $356.8 | AMF |